Inventor
Rudnitskaya Aleksandra
US53 patents
⚠️ This page may combine multiple inventors who share the name “Rudnitskaya Aleksandra”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
34 patentsUS10112915B2Oct 30, 2018
3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC41 citations99
US10494353B2Dec 3, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10494354B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10472337B2Nov 12, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10450284B2Oct 22, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC14 citations98
US10450283B2Oct 22, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC14 citations98
US10442776B2Oct 15, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10428031B2Oct 1, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10421731B2Sep 24, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10421732B2Sep 24, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC16 citations98
US10414738B2Sep 17, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC16 citations98
US10377726B2Aug 13, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC22 citations98
US10239845B2Mar 26, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC25 citations98
US10214500B2Feb 26, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC20 citations98
US10214501B2Feb 26, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC20 citations98
US9637453B2May 2, 2017
3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
FORMA THERAPEUTICS INC51 citations98
US9630922B2Apr 25, 2017
3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors
FORMA THERAPEUTICS INC49 citations98
US10407418B2Sep 10, 2019
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC16 citations94
US10183934B2Jan 22, 2019
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC27 citations94
US10513501B2Dec 24, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC11 citations93
US10494352B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10494351B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10479772B2Nov 19, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC6 citations93
US10464909B2Nov 5, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10464910B2Nov 5, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10457652B2Oct 29, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10266487B2Apr 23, 2019
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC4 citations84
US9745253B2Aug 29, 2017
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC10 citations84
US10508077B2Dec 17, 2019
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC2 citations73
US10508088B2Dec 17, 2019
Methods using HDAC11 inhibitors
FORMA THERAPEUTICS INC3 citations73
US10501424B2Dec 10, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC1 citations73
US10370343B2Aug 6, 2019
[6,6] Fused bicyclic HDAC8 inhibitors
FORMA THERAPEUTICS INC2 citations73
US10538496B2Jan 21, 2020
Methods using HDAC11 inhibitors
FORMA THERAPEUTICS INC3 citations72
US10029995B2Jul 24, 2018
[6,6] fused bicyclic HDAC8 inhibitors
FORMA THERAPEUTICS INC3 citations71
VALO HEALTH INC
9 patentsUS11279681B2Mar 22, 2022
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC6 citations94
US11702412B2Jul 18, 2023
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC4 citations86
US12264137B2Apr 1, 2025
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC0 citations73
US11891365B2Feb 6, 2024
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC1 citations73
US11345672B2May 31, 2022
Methods using HDAC11 inhibitors
VALO HEALTH INC2 citations73
US11274084B2Mar 15, 2022
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC1 citations73
US11274085B2Mar 15, 2022
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC0 citations73
US12304904B2May 20, 2025
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC0 citations63
US11535607B2Dec 27, 2022
Isoindolines as HDAC inhibitors
VALO HEALTH INC2 citations63
VALO EARLY DISCOVERY INC
7 patentsUS10829461B2Nov 10, 2020
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC15 citations98
US10829462B2Nov 10, 2020
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC15 citations98
US10822316B2Nov 3, 2020
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC10 citations93
US10988450B2Apr 27, 2021
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC6 citations92
US10870645B2Dec 22, 2020
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC9 citations84
US10988441B2Apr 27, 2021
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
VALO EARLY DISCOVERY INC1 citations73
US10829460B2Nov 10, 2020
[6,6] fused bicyclic HDAC8 inhibitors
VALO EARLY DISCOVERY INC1 citations73
Showing the top 50 of 53 patents by PatentIndex Score.